Physician profile
Gregory J Condon
NPI 1477512291
$3,916.76
in general payments reported to CMS, 2019-2025
32 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,473 · 2020: $359 · 2022: $64.08 · 2023: $21.48.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $21.48.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $21.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $511.97 | 2019-2020 | |
| Allergan, INC. | $314.02 | 2019-2020 | |
| Amgen INC. | $250.14 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $222.91 | 2019 | |
| Lilly USA, LLC | $221.97 | 2019 | |
| Sunovion Pharmaceuticals INC. | $214.62 | 2019 | |
| Avanir Pharmaceuticals, INC. | $212.49 | 2019-2020 | |
| Ucb, INC. | $196.39 | 2019-2020 | |
| Supernus Pharmaceuticals, INC. | $185.62 | 2019 | |
| Alexion Pharmaceuticals, INC. | $163.99 | 2019-2020 | |
| Eisai INC. | $150.83 | 2019 | |
| Acadia Pharmaceuticals INC | $138.84 | 2019 | |
| Tanabe Pharma America, INC. | $113.71 | 2019 | |
| Emd Serono, INC. | $111.63 | 2019 | |
| Biogen, INC. | $99.80 | 2019-2020 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $99.20 | 2019 | |
| Lundbeck LLC | $91.28 | 2019 | |
| Acorda Therapeutics, INC | $82.18 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $75.61 | 2019 | |
| Genentech USA, INC. | $72.65 | 2019-2020 | |
| Grifols USA, LLC | $70.94 | 2019-2020 | |
| Boston Scientific Corporation | $64.08 | 2022 | |
| Csl Behring | $49.56 | 2019 | |
| Mdd US Operations, LLC | $37.78 | 2019 | |
| Akcea Therapeutics, INC. | $36.64 | 2019 | |
| Assertio Therapeutics, INC. | $28.44 | 2019 | |
| Jazz Pharmaceuticals INC. | $23.04 | 2019 | |
| Abbvie INC. | $21.48 | 2023 | Botox |
| Ge Healthcare | $17.42 | 2020 | |
| Upsher-Smith Laboratories LLC | $15.13 | 2019 | |
| Amneal Pharmaceuticals LLC | $11.29 | 2019 | |
| Zyla Life Sciences, INC. | $11.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Condon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.